Digital Anticipatory Protocols at Triage to Improve ED Flow.

July 20, 2026 updated by: Hôpital Fribourgeois

Implementing Digital Anticipatory Protocols at Triage to Improve Emergency Department Flow: A Before-After Study Protocol

This study aims to evaluate a pre-post intervention adding an early management decision at the end of the triage process to improve patient throughput. The intervention consists of adding digital checkboxes to the electronic triage system, providing nurses with formalized options for anticipated management based on patient acuity. The study compares a pre-intervention phase (May 1st to July 31st, 2026) with a post-intervention phase (May 1st to July 31st, 2027) to naturalize seasonal confounders. The primary outcome is the total Emergency Department Length of Stay (ED LOS).

Study Overview

Study Type

Observational

Enrollment (Estimated)

15500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Canton of Fribourg
      • Villars-sur-Glâne, Canton of Fribourg, Switzerland, 1752

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population comprises all adult patients (over 18 years old) presenting to the emergency department of the cantonal hospital in Fribourg (HFR), Switzerland, during the predefined study periods (Phase 1 and Phase 2). The HFR is a university teaching and research hospital that manages approximately 41,000 ED visits annually.

Description

Inclusion Criteria:

  • All patients over 18 years who registered at the admission desk during the study period.

Exclusion Criteria:

  • Arrival by emergency medical services (ambulance or helicopter)
  • Patient trajectory bypassing the standard nurse-led triage process
  • Patient directly referred to another service of the hospital after triage (gynecology, ophthalmology, etc.).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Phase 1 - Pre-intervention
Patients presenting to the emergency department between May 1st and July 31st, 2026. Patients undergo standard triage assessment performed using the revised Swiss Emergency Triage Scale (SETS). Disposition decisions are monitored using a digital tag in the electronic health records.
Phase 2 - Post-intervention
Patients presenting to the emergency department between May 1st and July 31st, 2027. Patients undergo triage with the addition of a new digital anticipatory protocol. Disposition decisions continue to be monitored using the same digital tag.
The intervention consists of adding digital checkboxes to the electronic triage system. This provides nurses with formalized options for anticipated management based on patient acuity, aiming to encourage and document anticipatory actions while stimulating clinical reasoning.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Emergency Department Length of Stay (ED LOS).
Time Frame: Through completion of the ED visit, up to a maximum of 72 hours.
The time interval from the completion of the patient's administrative registration to their physical departure from the ED
Through completion of the ED visit, up to a maximum of 72 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Left without being seen (LWBS)
Time Frame: Through completion of the ED visit, up to a maximum of 72 hours.
Proportion of patients who registered at the ED admission desk and left before receiving a medical screening exam or an evaluation by a physician
Through completion of the ED visit, up to a maximum of 72 hours.
30-day mortality
Time Frame: Up to 30 days post-ED visit
Assessed through institutional medical records to evaluate safety
Up to 30 days post-ED visit
Intesive Care Unit (ICU) transfers
Time Frame: Up to 7 days post-ED visit
Proportion of patients transferred to the Intensive Care Unit (ICU) immediately and within 7 days after the ED visit
Up to 7 days post-ED visit

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time From Triage Assessment to Disposition Decision
Time Frame: Through completion of the ED visit, up to a maximum of 72 hours.

The time interval, measured in minutes, elapsed from the beginning of the nursing triage assessment to the exact moment a definitive disposition decision (e.g., discharge, admission) is entered by the emergency physician.

A disposition decision is operationally defined as the precise moment the attending emergency physician determines that active emergency care is complete. This includes the decision to transfer the patient to a hospital ward (for admissions) or the conclusion of clinical management (for discharges), even if the patient remains in the emergency department awaiting purely logistical arrangements, such as medical transport or family arrival. The measurement tool used to assess and timestamp this outcome is a standardized digital disposition decision tag integrated into the electronic health record.

Through completion of the ED visit, up to a maximum of 72 hours.
Time From Treatment Room Placement to Disposition Decision
Time Frame: Through completion of the ED visit, up to a maximum of 72 hours.

The time interval, measured in minutes, elapsed from when the patient is placed in an ED treatment room to the exact moment a definitive disposition decision (e.g., discharge, admission) is entered by the emergency physician.

A disposition decision is operationally defined as the precise moment the attending emergency physician determines that active emergency care is complete. This includes the decision to transfer the patient to a hospital ward (for admissions) or the conclusion of clinical management (for discharges), even if the patient remains in the emergency department awaiting purely logistical arrangements, such as medical transport or family arrival. The measurement tool used to assess and timestamp this outcome is a standardized digital disposition decision tag integrated into the electronic health record.

Through completion of the ED visit, up to a maximum of 72 hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Youcef Guechi, MD, Hopital Cantonal Fribourgeois (HFR)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

July 14, 2026

First Submitted That Met QC Criteria

July 20, 2026

First Posted (Actual)

July 24, 2026

Study Record Updates

Last Update Posted (Actual)

July 24, 2026

Last Update Submitted That Met QC Criteria

July 20, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Req-2026-00230

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data sharing is restricted by the Swiss Human Research Act and local ethics committee (Swissethics) due to the retrospective/observational nature of this quality improvement project and the lack of explicit patient consent for public open-data sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Length of Stay

Clinical Trials on Digital Anticipatory Protocols at Triage

Subscribe